However, the company stated that its latest trials still met key goals related to efficacy and tolerability
But because people on semaglutide or tirzepatide lose more weight in the first place, they all end up returning to baseline at approximately the same time, study senior researcher Dimitrios Koutoukidis of Oxford University told Reuters
For individuals with obesity but no diabetes, GLP-1 therapy increased health care costs with no significant reduction in obesity-related health issues over two years
February 18, 2026: Ozempic Manufacturer Runs $20 Million Super Bowl Ad Despite Mounting Lawsuits Novo Nordisk, which makes the GLP-1 drugs Ozempic and Wegovy, aired a high-profile ad during Super Bowl LX that reportedly cost more than $20 million
Midis personalized weight loss solutions, including GLP-1 prescriptions and other weight loss medications, can help you lose weight your way